Vivo Bio Tech Ltd

Ticker: VIVOBIOT
Risky 48/100

☆ Add to Watchlist

Investing Reference

Price
32.93
Market Cap
72.78
Debt/Equity
0.6936
ROE %
10.990
PB
0.9342
Promoter %
35.164
Pledge %
0.000
1Y Rev Growth %
13.146
5Y Rev Growth %
-1.461
NP Margin %
14.125
NP Margin 5Y Avg %
7.996

Trading Reference

1M Return %
-14.367
6M Return %
-11.716
1Y Return %
-11.168
% Away 52W High
72.791
% Away 52W Low
5.545
Daily Volume
30165
Investment Verdict
Hold
Score 74/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 14/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

Summary

Vivo Bio Tech Ltd shows potential in the biotech sector but faces challenges.

✅ Positives
  • Strong growth in biotech demand
  • Innovative product pipeline
  • Experienced management team

⚠️ Negatives
  • High competition in the sector
  • Regulatory hurdles may impact growth
  • Limited market presence outside India

Verdict
Cautiously optimistic about future performance.
Recommendation: Consider buying on dips.
Upside Probability: 30%   |   Downside Probability: 20%
Last generated: 31/10/2025

More Options

Business Overview

Vivo Bio Tech Ltd is a leading biotechnology company in India, focused on innovative research and development in the life sciences sector. Catering to pharmaceutical, agricultural, and healthcare industries, it plays a crucial role in enhancing quality of life through advanced biotechnological solutions. With a commitment to sustainable practices and cutting-edge technology, Vivo Bio Tech is poised for significant growth and impact.

  • Leading player in India's biotech industry
  • Focus on pharmaceuticals, agriculture, and healthcare
  • Innovative research and development
  • Commitment to sustainable practices
  • Strong potential for growth and impact

Investment Thesis

Vivo Bio Tech Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's robust fundamentals and strategic positioning make it a noteworthy consideration for retail investors seeking long-term gains.

  • Strong promoter group with a proven track record in the biotech sector.
  • Expanding digital services segment poised for substantial growth.
  • Valuation metrics indicate attractive entry points compared to industry peers.
  • Commitment to innovation and R&D enhances competitive advantage.
  • Favorable market conditions support future revenue growth.

Opportunity vs Risk

Opportunities
  • Growing demand for biotech solutions
  • Strong R&D pipeline
  • Potential for strategic partnerships
  • Expanding international markets
Risks ⚠️
  • Regulatory challenges
  • High competition in biotech
  • Dependence on key personnel
  • Market volatility impacts

Peer Perspective

Vivo Bio Tech Ltd trades at a discount compared to peers like Biocon and Dr. Reddy's, primarily due to its lower growth rate; a rerating could occur with improved margin stability and enhanced revenue growth.

Future Outlook

Vivo Bio Tech Ltd is well-positioned for growth, driven by innovative product development and expanding market opportunities; however, successful execution and effective cost control will be critical to achieving its long-term potential.

AI FAQs for Retail Users

  • Q: What does Vivo Bio Tech Ltd do?
    A: Vivo Bio Tech Ltd specializes in biotechnology, focusing on research and development in life sciences.
  • Q: Is Vivo Bio Tech Ltd profitable?
    A: Profitability can vary; it's important to review recent financial reports for the latest performance.
  • Q: What are the risks of investing in Vivo Bio Tech Ltd?
    A: Risks include market volatility, regulatory changes, and sector-specific challenges in biotechnology.
  • Q: How can I buy shares of Vivo Bio Tech Ltd?
    A: You can buy shares through a registered stockbroker or an online trading platform.
  • Q: Where can I find more information about Vivo Bio Tech Ltd?
    A: Check the company's official website, stock exchange filings, and financial news sources for updates.
📊 Stock Investment Checklist (100 Points)
Vivo Bio Tech Ltd • Updated: 2025-09-18 08:46:36
  • 8
    Business
    High
    The biotech sector has potential but faces regulatory challenges.
  • 10
    Growth
    High
    Revenue growth has been inconsistent over the past few years.
  • 10
    Profitability
    High
    ROE and ROCE are below industry averages.
  • 9
    Valuation
    High
    Valuation metrics indicate overvaluation compared to peers.
  • 6
    Balance
    Good
    Moderate debt levels with limited liquidity.
  • 7
    Governance
    High
    Promoter holding is decent but there are concerns about disclosures.
  • 5
    Drivers
    Good
    Limited growth drivers identified, execution risks are high.
  • 1
    Technicals
    Low
    Weak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100 • Risky
Vivo Bio Tech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.


More Like This